Pathologic Response and Locoregional Outcome in Post-menopausal ER Positive Breast Cancer Patients Receiving Neoadjuvant Endocrine Therapy vs. Cytotoxic ChemotherapyKunal Saigal, Jean L. Wright, T. Ambros et al.|International Journal of Radiation Oncology*Biology*Physics|2011Cited by 2
Association between race and BMI with response to neoadjuvant endocrine therapy in postmenopausal women with large estrogen receptor-positive breast cancers.T. Ambros, Judith Hurley, Victoria Sujoy et al.|Journal of Clinical Oncology|2011Cited by 1
Traditional Risk Factors for Locoregional Recurrence May Not Be Predictive in Postmenopausal Women With ER-Positive Breast Cancer Treated With Neoadjuvant TherapyKunal Saigal, Jean L. Wright, T. Ambros et al.|International Journal of Radiation Oncology*Biology*Physics|2013Cited by 0